PCV79 Compliance With Warfarin Therapy by Australian Patients With Atrial Fibrillation

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.1022
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation

Archives of Internal Medicine
2012English

Incidence of Major Bleeding Complication of Warfarin Therapy in Japanese Patients With Atrial Fibrillation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2007English

Examining Warfarin Underutilization Rates in Patients With Atrial Fibrillation: Detailed Chart Review Essential to Capture Contraindications to Warfarin Therapy

Thrombosis Journal
Hematology
2008English

The SAMe-TT2R2 Score Predicts Warfarin Control in an Australian Population With Atrial Fibrillation

Journal of Clinical Medicine
2019English

Anticoagulation in Patients With Atrial Fibrillation. Underuse of Warfarin Is Multifactorial.

BMJ
1993English

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion

Circulation
Cardiovascular MedicinePhysiologyCardiology
2011English

Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin

Archives of Internal Medicine
2006English

Under-Use of Warfarin for Patients With Non-Valvular Atrial Fibrillation in Japan

Internal Medicine
Internal MedicineMedicine
2004English

Outcomes in a Warfarin-Treated Population With Atrial Fibrillation

JAMA Cardiology
Cardiovascular MedicineCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy